Dopamine Agonists Can Reduce Cystic Prolactinomas | Zendy

Alexander T. Faje | Zendy; Paweena Chunharojrith | Zendy; Joshipura Nency | Zendy; Beverly M. K. Biller | Zendy; Brooke Swearingen | Zendy; Anne Klibanski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dopamine Agonists Can Reduce Cystic Prolactinomas

Author(s) -

Alexander T. Faje,

Paweena Chunharojrith,

Joshipura Nency,

Beverly M. K. Biller,

Brooke Swearingen,

Anne Klibanski

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-2008

Subject(s) - cyst , medicine , interquartile range , hypopituitarism , retrospective cohort study , transsphenoidal surgery , surgery , optic chiasm , pituitary adenoma , gastroenterology , adenoma , anatomy , optic nerve

Cystic prolactinomas are considered resistant to volume reduction by dopamine agonists (DAs). Although several individual case reports and small case series have suggested that DAs may reduce these lesions, larger series using standardized imaging metrics are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research